Acrivon Therapeutics, Inc. (ACRV)

NASDAQ: ACRV · IEX Real-Time Price · USD

8.86

+0.49 (5.85%)

At close: Jul 26, 2024, 4:00 PM

8.93

+0.07 (0.79%)

After-hours: Jul 26, 2024, 6:36 PM EDT

Acrivon Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	274	109	241	-	-
Market Cap Growth	-41.82%	-54.61%	-	-	-
Enterprise Value	156	-28	291	-	-
Last Close Price	7.15	4.92	11.52	-	-
PE Ratio	-	-1.80	-1.52	-	-
PB Ratio	2.43	0.90	1.41	-	-
P/FCF Ratio	-3.21	-2.49	-7.45	-	-
P/OCF Ratio	-3.35	-2.56	-7.99	-	-
EV/EBITDA Ratio	-0.56	0.43	-9.02	-	-
EV/EBIT Ratio	-0.55	0.42	-8.92	-	-
EV/FCF Ratio	-0.77	0.65	-9.03	-	-
Debt / Equity Ratio	0.04	0.04	0.03	0.06	0.04
Debt / FCF Ratio	-0.09	-0.11	-0.15	-0.40	-0.02
Quick Ratio	12.16	9.58	19.61	34.18	2.58
Current Ratio	12.40	9.75	20.27	34.46	2.80
Return on Equity (ROE)	-47.77%	-41.41%	-23.16%	-32.39%	-
Return on Assets (ROA)	-30.26%	-26.25%	-14.18%	-18.60%	-
Return on Capital (ROIC)	-31.68%	-27.84%	-14.59%	-19.09%	-
Earnings Yield	-24.46%	-55.30%	-12.95%	-	-
FCF Yield	-19.24%	-40.23%	-13.42%	-	-
Buyback Yield / Dilution	-3.06%	-435.63%	-136.43%	-21.70%	-
Total Shareholder Return	-3.06%	-435.63%	-136.43%	-21.70%	-

Source: S&P Capital IQ. Standard template.